Antitrust Antitrust

Lonza, Quidel change business practices after EU antitrust scrutiny

By Lewis Crofts
  • 20 Jul 2022 17:25
  • 20 Jul 2022 17:25
Swiss biotech company Lonza and US diagnostic specialist Quidel have both ended business practices suspected of being anticompetitive after the European Commission looked into complaints about them.
The EU watchdog has now closed its inquiries, which came to light last week when the commission published its 2021 annual report trumpeting

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Lewis Crofts


Lewis leads MLex's editorial strategy, content direction, quality and development. He has a reputation for breaking stories and providing analysis on complex legal disputes before regulators and courts around the globe. He has also developed MLex's unrivalled coverage of competition policy, litigation, regulation, Brexit and international investigations.

Discover MLex

Stay on top of global regulatory developments

Latest News